Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q3 2022 Earnings Call Transcript
Juli Miller: Good morning and welcome to Adaptimmunes conference call to discuss our third quarter 2022 financial results and business update.
Source: insidermonkey.com